Literature DB >> 6807682

Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.

P Magill, S N Rao, N E Miller, A Nicoll, J Brunzell, J St Hilaire, B Lewis.   

Abstract

In order to gain further insight into the relationship between high-density lipoprotein (HDL) metabolism and plasma triglyceride transport, measurements were made of HDL cholesterol concentration, apoprotein (apo) AI and AII metabolism, very-low-density-lipoprotein (VLDL) apo B metabolism, and heparin-elutable adipose tissue lipoprotein lipase (LPL) activity in seventeen subjects with a wide range of plasma triglyceride concentrations (0.8-25 mmol/l). The fractional catabolic rate (FCR) of VLDL apo B was directly related to LPL activity (r = +0.80), providing evidence that the activity of the enzyme in adipose tissue is a determinant of the rate of lipolysis of VLDL in man. HDL cholesterol concentration was a positive function of both VLDL apo B FCR (r = +0.74) and LPL activity, a finding consistent with previous evidence for the origin of a proportion of HDL cholesterol from 'surface remnants' liberated during VLDL catabolism. THe FCRs of both apo AI and apo AII were inversely related to VLDL apo B FCR (AI, r = -0.52; AII, r = -0.69) and to LPL activity. The synthetic rate of ap AII, but not that of apo AI, was positively correlated with VLDL apo B synthesis (r = +0.7 1). Thus, the metabolism of the major proteins of HDl in man appears to be closely associated with VLDL metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807682     DOI: 10.1111/j.1365-2362.1982.tb00947.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels.

Authors:  C Heizmann; T Kirchgessner; P O Kwiterovich; J A Ladias; C Derby; S E Antonarakis; A J Lusis
Journal:  Hum Genet       Date:  1991-04       Impact factor: 4.132

3.  Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

Authors:  J Shepherd; C J Packard; J M Stewart; R F Atmeh; R S Clark; D E Boag; K Carr; A R Lorimer; D Ballantyne; H G Morgan
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

4.  Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

Authors:  M S Weintraub; R Zechner; A Brown; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Effect of moderate to very low fat defined formula diets on serum lipids in healthy subjects.

Authors:  J T Snook; J P DeLany; V M Vivian
Journal:  Lipids       Date:  1985-11       Impact factor: 1.880

6.  Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

Authors:  J E Hokanson; J D Brunzell; G P Jarvik; E M Wijsman; M A Austin
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

Authors:  S Imamura; J Kobayashi; K Nakajima; S Sakasegawa; A Nohara; T Noguchi; M A Kawashiri; A Inazu; S S Deeb; H Mabuchi; J D Brunzell
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

8.  Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.

Authors:  Lawrence W Castellani; Cara N Nguyen; Sarada Charugundla; Michael M Weinstein; Chau X Doan; William S Blaner; Nuttaporn Wongsiriroj; Aldons J Lusis
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

9.  Synergistic effect between lipoprotein lipase and apolipoprotein C3 genes in determining the severity of coronary artery disease.

Authors:  Tarek A Abd-El-Aziz; Randa H Mohamed; Amal S El-Shal
Journal:  J Cardiovasc Transl Res       Date:  2013-02-02       Impact factor: 4.132

10.  Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M R Taskinen; J Kahri; V Koivisto; J Shepherd; C J Packard
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.